-
60928-50Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which promote the differentiation of monocytes and activate polymorphonuclear leukocytes. One of these substances was recently isolated and purified from oxLDL,
-
13741-1A potent, selective EP2 receptor agonist (Ki = 73 nM).
-
13741-10A potent, selective EP2 receptor agonist (Ki = 73 nM).
-
13741-5A potent, selective EP2 receptor agonist (Ki = 73 nM).
-
13741-500A potent, selective EP2 receptor agonist (Ki = 73 nM).
-
13740-1Butaprost, a structural analog of PGE2, is a selective agonist for the EP2 receptor subtype. EP2 receptors are expressed on human neutrophils and on respiratory, vascular, and uterine smooth muscle.
-
13740-10Butaprost, a structural analog of PGE2, is a selective agonist for the EP2 receptor subtype. EP2 receptors are expressed on human neutrophils and on respiratory, vascular, and uterine smooth muscle.
-
13740-5Butaprost, a structural analog of PGE2, is a selective agonist for the EP2 receptor subtype. EP2 receptors are expressed on human neutrophils and on respiratory, vascular, and uterine smooth muscle.
-
13740-500Butaprost, a structural analog of PGE2, is a selective agonist for the EP2 receptor subtype. EP2 receptors are expressed on human neutrophils and on respiratory, vascular, and uterine smooth muscle.
-
15371-1A plant polyphenol that is classified as a chalcone a potent antioxidant that affects the numerous pathways modulated by oxidant tone, including inflammation, cancer, and immune response.
-
15371-10A plant polyphenol that is classified as a chalcone a potent antioxidant that affects the numerous pathways modulated by oxidant tone, including inflammation, cancer, and immune response.
-
15371-5A plant polyphenol that is classified as a chalcone a potent antioxidant that affects the numerous pathways modulated by oxidant tone, including inflammation, cancer, and immune response.